A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time.

A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time.
复制标题

DOI:
10.3390/pathogens11030368
复制
发表时间:
2022-03-17
期刊:
Pathogens (Basel, Switzerland)
影响因子:
--
通讯作者:
Anderson SH
Anderson SH
中科院分区:
其他
文献类型:
--
作者:
Al-Awwal N;Dweik F;Mahdi S;El-Dweik M;Anderson SH

文献摘要

参考文献

被引文献

相似文献

在最近由SARS-CoV-2感染引起的冠状病毒肺炎(COVID-19)疫情在全球迅速蔓延期间,开发和部署用于快速检测2019年新型严重急性呼吸综合征-冠状病毒2 (SARS-CoV-2)的生物传感器至关重要和紧迫。2022年2月确认的病例表明,全球有170多个国家受到影响。最近的证据表明,全球有超过4.3亿确诊病例,超过592万人死亡,其中美国有超过7800万确诊病例,超过92万人死亡。美国现在的病例比中国多得多,中国于2019年12月底首次报告了冠状病毒病例。疫情最初发生在中国,许多领导人没有预料到疫情会蔓延到全球,蔓延到许多国家,对全球健康构成严重威胁。本文综述了COVID-19的起源、生物学性质、与其他冠状病毒的比较、症状、预防、治疗、潜在的、现有的SARS-CoV-2检测方法以及COVID-19后症状。
Development and deployment of biosensors for the rapid detection of the 2019 novel severe acute respiratory syndrome—coronavirus 2 (SARS-CoV-2) are of utmost importance and urgency during this recent outbreak of coronavirus pneumonia (COVID-19) caused by SARS-CoV-2 infection, which spread rapidly around the world. Cases now confirmed in February 2022 indicate that more than 170 countries worldwide are affected. Recent evidence indicates over 430 million confirmed cases with over 5.92 million deaths scattered across the globe, with the United States having more than 78 million confirmed cases and over 920,000 deaths. The US now has many more cases than in China where coronavirus cases were first reported in late December 2019. During the initial outbreak in China, many leaders did not anticipate it could reach the whole world, spreading to many countries and posing severe threats to global health. The objective of this review is to summarize the origin of COVID-19, its biological nature, comparison with other coronaviruses, symptoms, prevention, treatment, potential, available methods for SARS-CoV-2 detection, and post-COVID-19 symptoms.
DOI: 10.1016/s2468-2667(21)00055-4
发表时间: 2021-05
期刊: The Lancet. Public health
影响因子: --
作者:
Graham MS;Sudre CH;May A;Antonelli M;Murray B;Varsavsky T;Kläser K;Canas LS;Molteni E;Modat M;Drew DA;Nguyen LH;Polidori L;Selvachandran S;Hu C;Capdevila J;COVID-19 Genomics UK (COG-UK) Consortium;Hammers A;Chan AT;Wolf J;Spector TD;Steves CJ;Ourselin S
通讯作者: Ourselin S
DOI: 10.1093/jac/dkab244
发表时间: 2021-09-23
期刊: The Journal of antimicrobial chemotherapy
影响因子: --
作者:
Chekuri S;Szymczak WA;Goldstein DY;Nori P;Marrero Rolon R;Spund B;Singh-Tan S;Mohrmann L;Assa A;Southern WN;Baron SW
通讯作者: Baron SW
DOI: 10.26355/eurrev_202109_26669
发表时间: 2021-01-01
影响因子: 3.3
作者:
Ahmad, M. S.;Shaik, R. A.;Almutairi, S. B.
通讯作者: Almutairi, S. B.
DOI: 10.1016/j.genrep.2022.101554
发表时间: 2022-06
期刊: Gene reports
影响因子: 1.3
作者:
Molina-Mora JA
通讯作者: Molina-Mora JA
DOI: 10.1016/j.rmed.2021.106383
发表时间: 2021-05
影响因子: 4.3
作者:
Froidure A;Mahsouli A;Liistro G;De Greef J;Belkhir L;Gérard L;Bertrand A;Koenig S;Pothen L;Yildiz H;Mwenge B;Aboubakar F;Gohy S;Pilette C;Reychler G;Coche E;Yombi JC;Ghaye B
通讯作者: Ghaye B